Maria Li Lung

Prof. Maria Li Lung

Department of Clinical Oncology at the University of Hong Kong
orcid

Research Focus & Metrics

Academic Career Length

49Years (1978-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HZHong Zheng
Hong Zheng
WDWei Dai
Wei Dai
ACArthur Kwok Leung Cheung
Arthur Kwok Leung Cheung
JKJosephine Ko
Josephine Ko
RKRebecca Kan
Rebecca Kan
MLMaria Li Lung
Maria Li Lung
Significance: Host genetics, environmental factors, and EBV infection together contribute to nasopharyngeal carcinoma (NPC) development. A number of critical genetic and epigenetic events contributing to tumor development has been reported. However, the genomic alterations in NPC have not been completely deciphered. We used the whole-exome sequencing approach to study the somatic mutations in NPC, and an APOBEC-mediated mutagenesis signature was revealed. Importantly, multiple loss-of-function mutations in the NF-κB–negative regulators (NFKBIA,CYLD, andTNFAIP3) were discovered in NPC tumors, and we functionally confirmed that theNFKBIAloss-of-function mutations induce damaging effects on the WT proteins. Detection of these mutations emphasizes the critical role of NF-κB signaling in NPC tumorigenesis and provides perspectives for targeting this pathway in NPC treatment.

16 November 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
CTChi Man Tsang
Chi Man Tsang
YYYim Ling Yip
Yim Ling Yip
KLKwok Wai Lo
Kwok Wai Lo
WDWen Deng
Wen Deng
KTKa Fai To
Ka Fai To
STSai Wah Tsao
Sai Wah Tsao
Undifferentiated nasopharyngeal carcinomas (NPCs) are commonly present with latent EBV infection. However, events regulating EBV infection at early stages of the disease and the role of EBV in disease pathogenesis are largely undefined. Genetic alterations leading to activation of cyclin D1 signaling in premalignant nasopharyngeal epithelial (NPE) cells have been postulated to predispose cells to EBV infection. We previously reported that loss of p16, a negative regulator of cyclin D1 signaling, is a frequent feature of NPC tumors. Here, we report that early premalignant lesions of nasopharyngeal epithelium overexpress cyclin D1. Furthermore, overexpression of cyclin D1 is closely associated with EBV infection. Therefore we investigated the potential role of cyclin D1 overexpression in dysplastic NPE cells in vitro. In human telomerase reverse transcriptase-immortalized NPE cells, overexpression of cyclin D1 or a p16-resistant form of CDK4 (CDK4 R24C ) suppressed differentiation. This suppression may have implications for the close association of EBV infection with undifferentiated NPC. In these in vitro models, we found that cellular growth arrest and senescence occurred in EBV-infected cell populations immediately after infection. Nevertheless, overexpression of cyclin D1 or a p16-resistant form of CDK4 or knockdown of p16 in the human telomerase reverse transcriptase-immortalized NPE cell lines could counteract the EBV-induced growth arrest and senescence. We conclude that dysregulated expression of cyclin D1 in NPE cells may contribute to NPC pathogenesis by enabling persistent infection of EBV.

1 April 2013 in Cancer Research
Verified
Journal Article
Closed access
PDF file
KTKwan Ho Tang
Kwan Ho Tang
YDYong Dong Dai
Yong Dong Dai
MTMan Tong
Man Tong
YCYuen Piu Chan
Yuen Piu Chan
PKPak Shing Kwan
Pak Shing Kwan
Xin-Yuan GuanXin-Yuan Guan
Xin-Yuan Guan
Tumor-initiating cells (TIC), also known as cancer stem cells, are regarded widely as a specific subpopulation of cells needed for cancer initiation and progression. TICs have yet to be identified in esophageal tumors that have an increasing incidence in developed countries. Here, we report a CD90+ cell population found in esophageal squamous cell carcinoma (ESCC), which is endowed with stem cell–like properties and high tumorigenic and metastatic potential. mRNA profiling of these cells suggested pathways through which they drive tumor growth and metastasis, with deregulation of an Ets-1/MMP signaling pathway and epithelial–mesenchymal transition figuring prominently. These cells possessed higher self-renewal activity and were sufficient for tumor growth, differentiation, metastasis, and chemotherapeutic resistance. CD90+ TICs were isolated and characterized from ESCC clinical specimens as well as ESCC cell lines. In freshly resected clinical specimens, they represented a rare cell population, the levels of which correlated with strong family histories and lymph node metastasis. Our results prompt further study of this CD90+ population of esophageal TICs as potential therapeutic targets. Cancer Res; 73(7); 2322–32. ©2013 AACR.

7 November 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
WLWeitao Lin
Weitao Lin
YYYim Ling Yip
Yim Ling Yip
LJLin Jia
Lin Jia
WDWen Deng
Wen Deng
HZHong Zheng
Hong Zheng
STSai Wah Tsao
Sai Wah Tsao
The lack of representative nasopharyngeal carcinoma (NPC) models has seriously hampered research on EBV carcinogenesis and preclinical studies in NPC. Here we report the successful growth of five NPC patient-derived xenografts (PDXs) from fifty-eight attempts of transplantation of NPC specimens into NOD/SCID mice. The take rates for primary and recurrent NPC are 4.9% and 17.6%, respectively. Successful establishment of a new EBV-positive NPC cell line, NPC43, is achieved directly from patient NPC tissues by including Rho-associated coiled-coil containing kinases inhibitor (Y-27632) in culture medium. Spontaneous lytic reactivation of EBV can be observed in NPC43 upon withdrawal of Y-27632. Whole-exome sequencing (WES) reveals a close similarity in mutational profiles of these NPC PDXs with their corresponding patient NPC. Whole-genome sequencing (WGS) further delineates the genomic landscape and sequences of EBV genomes in these newly established NPC models, which supports their potential use in future studies of NPC.

1 April 2016 in Chinese Clinical Oncology
Verified
Journal Article
Open access
WDWei Dai
Wei Dai
HZHong Zheng
Hong Zheng
ACArthur Kwok Leung Cheung
Arthur Kwok Leung Cheung
MLMaria Li Lung
Maria Li Lung
Nasopharyngeal carcinoma (NPC) is a unique epithelial malignancy that shows a remarkable geographical and ethic distribution. Multiple factors including predisposing genetic factors, environmental carcinogens, and Epstein-Barr virus (EBV) infection contribute to the accumulation of genetic and epigenetic alterations leading to NPC development. Emerging technologies now allow us to detailedly characterize and understand cancer genomes. Genome-wide studies show that typically NPC tumors are characterized as having comparatively low mutation rates, widespread hypermethylation, and frequent copy number alterations and chromosome abnormalities. In this review, we provide an updated overview of the genetic and epigenetic aberrations that likely drive nasopharyngeal tumor development and progression. We integrate the previous knowledge and novel findings from whole-exome sequencing (WES) and methylome studies in NPC, and further discuss the potential use of these findings to identify biomarkers for NPC diagnosis and prognosis.

20 June 2005 in Oncogene
Verified
Journal Article
Closed access
HLHong Lok Lung
Hong Lok Lung
DBDhinoth Kumar Bangarusamy
Dhinoth Kumar Bangarusamy
DXDan Xie
Dan Xie
ACArthur Kwok Leung Cheung
Arthur Kwok Leung Cheung
YCYue Cheng
Yue Cheng
MLMaria Li Lung
Maria Li Lung